Top story

RFK Jr. to Allow Broad Use of Unapproved Peptide Injections

In a unilateral declaration by the health secretary, several injections promoted by online influencers will become widely available. The F.D.A. had advised against the move.

Read full story

ESSENCE Phase 3 Trial of Semaglutide Showed Significant Improvements at 72 Weeks in Adults with MASH, Published in NEJM

Drugs.com - Clinical Trial Results
Wed, 30 Apr 2025
Read more

Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application for Elamipretide

Drugs.com - New Drug Applications
Tue, 29 Apr 2025
Read more

Sebela Pharmaceuticals Announces Positive Topline Results from Phase 3 TRIUMpH Program of Tegoprazan in GERD

Drugs.com - Clinical Trial Results
Wed, 23 Apr 2025
Read more

NIH Study Reveals How Inflammation Makes Touch Painful

Drugs.com - Clinical Trial Results
Wed, 23 Apr 2025
Read more

African Vaccination Week 2025

WHO Regional Office for Africa
By elombatd@who.int - Tue, 22 Apr 2025
Read more

World Health Day 2025

WHO Regional Office for Africa
By elombatd@who.int - Tue, 15 Apr 2025
Read more

H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics

The New York Times - Drugs & Pharmaceuticals
By Carl Zimmer and Apoorva Mandavilli - Wed, 26 Mar 2025
Read more

FDA Approves Vykat XR (diazoxide choline) to Treat Hyperphagia in Prader-Willi Syndrome

Drugs.com - New Drug Approvals
Wed, 26 Mar 2025
Read more

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors

Drugs.com - New Drug Approvals
Wed, 26 Mar 2025
Read more